Results 11 to 20 of about 756,852 (217)
Case Report : Generalized Myasthenia Gravis [PDF]
Medicinus, 2020 Generalized myasthenia gravis is a rare case of autoimmune wherein the antibodies destroy the post-sinaptic acetylcholine receptors at skeletal muscle’s neuromuscular junctions. The clinical presentation is specific distributin of motoric deficit without
Widjaja, Devita, Puspitasari, Vivien
core +3 more sources
Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen [PDF]
, 2002 The weakness in myasthenia gravis (MG) is mediated by autoantibodies against adult muscle acetylcholine receptors (AChR) at the neuromuscular junction; most of these antibodies also bind to fetal AChR, which is present in the thymus.
Wilcox, Nick +13 more
core +1 more source
Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis [PDF]
Korean Journal of Ophthalmology, 2011 To compare the clinical manifestations between patients with ocular myasthenia gravis and those with generalized myasthenia gravis (MG).The medical records of 71 patients diagnosed with MG between January 1995 and December 2007 were reviewed. Demographics, sensitivities of diagnostic methods, the presence of systemic autoimmune diseases, ophthalmic ...
Roh, Hyun Seok +2 more
openaire +3 more sources
Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS [PDF]
, 2012 Myasthenia Gravis (MG) patients suffer from chronic fatigue of skeletal muscles, even after initiation of proper immunosuppressive medication. Since the localization of neuronal nitric oxide synthase (nNOS) at the muscle membrane is important for ...
Meinen, Sarina +7 more
core +2 more sources
Association of Smoking and Generalized Manifestations of Myasthenia Gravis
Internal Medicine, 2022 Objective Smoking is a known risk factor for the development and progression of autoimmune diseases. Previous studies in ocular myasthenia gravis (MG) patients showed that smoking is associated with the severity of symptoms and progression to generalized MG.
Miyazaki, Yusei +9 more
openaire +3 more sources
Myasthenia Gravis Revealing Hodgkin’s Lymphoma
European Journal of Case Reports in Internal Medicine, 2021 Introduction: Myasthenia gravis is a rare autoimmune disease caused by autoantibodies directed against the synapses of the neuromuscular junction. Patient and methods: We report the case of a young patient with myasthenia gravis associated with Hodgkin ...
Jaouad Yousfi +4 more
doaj +1 more source
Assessment of the Myasthenia Gravis Patients’ Quality of Life
Pielęgniarstwo Neurologiczne i Neurochirurgiczne, 2023 Introduction. Myasthenia gravis is an immune-mediated disease associated with a disorder of the neuromuscular junction. MG belongs to the group of chronic diseases with variable clinical courses.
Weronika Jung-Plath +3 more
doaj +1 more source
Neurologijos seminarai, 2022 Myasthenia gravis is a chronic autoimmune neuromuscular disorder typically presenting with variable skeletal muscle fatigue. The most prevalent initial manifestation of myasthenia is ocular myasthenia.
J. Zakaravičiūtė, M. Šerelytė
doaj +3 more sources
Eculizumab: A Review in Generalized Myasthenia Gravis [PDF]
Drugs, 2018 The humanized monoclonal antibody eculizumab (Soliris®) is a complement inhibitor indicated for use in anti-acetylcholine receptor (AChR) antibody-positive adults with generalized myasthenia gravis (gMG) in the USA, refractory gMG in the EU, or gMG with symptoms that are difficult to control with high-dose IVIg therapy or PLEX in Japan. It is the first
openaire +2 more sources